-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on Aveanna Healthcare Hldgs, Raises Price Target to $15

Benzinga·08/28/2026 14:48:07
Listen to the news
Barclays analyst Andrew Mok maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Overweight and raises the price target from $9.5 to $15.